Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cell Vaccine in Sezary Syndrome
NCT00099593Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Sep 2004
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous dendritic cell vaccine in Sézary syndrome (SS), sponsored by University of Pittsburgh. Started Sep 2004; status: completed.
02
Drugs
autologous dendritic cell vaccine
03
Conditions
Sézary syndrome (SS)
Beyond the preview
Go deeper on NCT00099593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099593.